dc.contributor.author | Ζερβούδης, Στέφανος | el |
dc.contributor.author | Ιατράκης, Γεώργιος Μ. | el |
dc.contributor.author | Ναυρόζογλου, Ιορδάνης | el |
dc.date.accessioned | 2015-05-12T16:19:14Z | |
dc.date.issued | 2015-05-12 | |
dc.identifier.uri | http://hdl.handle.net/11400/10219 | |
dc.rights | Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.source | http://www.bestpracticeobgyn.com/ | en |
dc.subject | Gynecology | |
dc.subject | Breast cancer | |
dc.subject | Chemotherapy | |
dc.subject | Age | |
dc.subject | Fertility preservation | |
dc.subject | Reproduction | |
dc.subject | Γυναικολογία | |
dc.subject | Καρκίνος του μαστού | |
dc.subject | Χημειοθεραπεία | |
dc.subject | Ηλικία | |
dc.subject | Διατήρηση της γονιμότητας | |
dc.subject | Αναπαραγωγή | |
dc.title | Reproduction after breast cancer | en |
heal.type | journalArticle | |
heal.classification | Medicine | |
heal.classification | Oncology | |
heal.classification | Ιατρική | |
heal.classification | Ογκολογία | |
heal.classificationURI | http://id.loc.gov/authorities/subjects/sh00006614 | |
heal.classificationURI | http://skos.um.es/unesco6/320713 | |
heal.classificationURI | **N/A**-Ιατρική | |
heal.classificationURI | **N/A**-Ογκολογία | |
heal.keywordURI | http://id.loc.gov/authorities/subjects/sh85058092 | |
heal.identifier.secondary | DOI: http://dx.doi.org/10.1016/j.bpobgyn.2009.08.008 show | |
heal.dateAvailable | 10000-01-01 | |
heal.language | en | |
heal.access | forever | |
heal.recordProvider | Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Μαιευτικής | el |
heal.publicationDate | 2010-02 | |
heal.bibliographicCitation | Zervoudis, S., Iatrakis, G. and Navrozoglou, I. (2010) Reproduction after breast cancer. In "Best Practice & Research Clinical Obstetrics & Gynaecology", 24 (1), p. 81-86. Available from: http://www.bestpracticeobgyn.com/article/S1521-6934%2809%2900111-4/abstract [Accessed: 12/05/2015]. | en |
heal.abstract | Breast cancer is the most frequently occurring cancer in women of developed countries, and as a result of new developments in breast cancer treatment, more women are cured after being diagnosed with this disease. It is important that fertility preservation strategies are addressed before chemotherapy, because chemotherapy may induce premature ovarian failure (depending on the woman's age, the drugs used, the dosage and duration of treatment). Among possible solutions are embryos or oocytes cryopreservation, ovarian tissue cryopreservation–freezing with a subsequent orthotopic and heterotopic autotransplantation, whole ovary cryopreservation, ovarian suppression with gonadotropin-releasing hormone (GnRH) analogues, which inhibit ovarian follicular depletion induced by chemotherapeutic agents and in vitro fertilisation (IVF) after ovulation induction with aromatase inhibitors or tamoxifen. | en |
heal.publisher | Elsevier | en |
heal.journalName | Best Practice & Research Clinical Obstetrics & Gynaecology | el |
heal.journalType | peer-reviewed | |
heal.fullTextAvailability | false |
Αρχεία | Μέγεθος | Μορφότυπο | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο. |
Οι παρακάτω άδειες σχετίζονται με αυτό το τεκμήριο: